US Stock MarketDetailed Quotes

EIGRQ Eiger BioPharmaceuticals

Watchlist
  • 11.950
  • -0.700-5.53%
15min DelayClose Jul 1 16:00 ET
17.70MMarket Cap-235P/E (TTM)

About Eiger BioPharmaceuticals Company

Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.

Company Profile

SymbolEIGRQ
Company NameEiger BioPharmaceuticals
Listing DateJan 30, 2014
Founded2008
CEODr. David Apelian, M.D.,PhD
MarketPink Market
Employees25
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2155 Park Boulevard
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94306-1543
Phone1-650-272-6138
Websitehttp://www.eigerbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. David Apelian, M.D.,PhD
  • Director and Chief Executive Officer
  • 204.39K
  • James Vollins
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • William G. Kachioff
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Michelle Maynard
  • Senior Vice President, Finance
  • --
  • Dr. Thomas J. Dietz, PhD
  • Chairman of the Board
  • 274.58K
  • Lisa Kelly-Croswell
  • Independent Director
  • 181.07K
  • Kim Sablich
  • Independent Director
  • 124.59K
  • Amit K. Sachdev, J.D.
  • Independent Director
  • 135.09K
  • Dr. Evan Loh, M.D.
  • Independent Director
  • 137.09K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg